Opus Genetics, Inc. (FRA:R3X1)

Opus Genetics Revenue

Opus Genetics had revenue of $3.08M USD in the quarter ending September 30, 2025, a decrease of -20.38%. This brings the company's revenue in the last twelve months to $14.63M, up 74.60% year-over-year. In the year 2024, Opus Genetics had annual revenue of $10.99M, down -42.30%.

• Revenue (ttm): $14.63M
• Revenue Growth: +74.60%
• P/S Ratio: 10.75
• Revenue / Employee: $812.94K
• Employees: 18
• Market Cap: 134.09M EUR

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	10.99M	-8.06M	-42.30%
Dec 31, 2023	19.05M	-20.80M	-52.20%
Dec 31, 2022	39.85M	39.26M	6,665.70%
Dec 31, 2021	589.00K	-	-
Dec 31, 2020	-	-	-
Dec 31, 2019	-	-	-
Dec 31, 2018	-	-	-
Dec 31, 2017	-	-	-
Dec 31, 2016	-	-	-
Dec 31, 2015	-	-	-
Dec 31, 2014	-	-	-
Dec 31, 2013	-	-	-
Dec 31, 2012	-	-	-
Dec 31, 2011	-	-	-
Dec 31, 2010	-	-	-
Dec 31, 2009	-	-	-
Dec 31, 2008	75.00K	-	-
Dec 31, 2007	75.00K	-	-